SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company to Present Phase II Rheumatoid Arthritis and Biomarker Data at ACR for Two Investigational Medicines to Treat Autoimmune Diseases